{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:00:10Z","timestamp":1793386810534,"version":"4.5.0"},"reference-count":42,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T00:00:00Z","timestamp":1646956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2022,12,31]]},"DOI":"10.1080\/13696998.2022.2046388","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T08:43:51Z","timestamp":1646383431000},"page":"367-380","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":19,"title":["Evaluation of treatment patterns, healthcare resource utilization, and costs among patients receiving treatment for cytomegalovirus following allogeneic hematopoietic cell or solid organ transplantation"],"prefix":"10.1080","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8281-2496","authenticated-orcid":false,"given":"Wendy Y.","family":"Cheng","sequence":"first","affiliation":[{"name":"Health Economics and Outcomes Research, Analysis Group, Inc, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7692-3619","authenticated-orcid":false,"given":"Robin K.","family":"Avery","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9047-3941","authenticated-orcid":false,"given":"Philippe","family":"Thompson-Leduc","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research, Analysis Group, Inc, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoi Ching","family":"Cheung","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research, Analysis Group, Inc, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien","family":"Bo","sequence":"additional","affiliation":[{"name":"Medical Affairs, Takeda Development Center Americas, Inc, Lexington, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5035-6687","authenticated-orcid":false,"given":"Mei Sheng","family":"Duh","sequence":"additional","affiliation":[{"name":"Health Economics and Outcomes Research, Analysis Group, Inc, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishan","family":"Hirji","sequence":"additional","affiliation":[{"name":"Global Evidence &amp; Outcomes, Takeda Development Center Americas, Inc, Lexington, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,3,11]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2016.031"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-679639"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000000160"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112666"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz003"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(15)00289-6"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2015(07)09"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-017-0180-z"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13512"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30107-0"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz454"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000002191"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12222"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/1469-0691.12594"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13521"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000001418"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy696"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq368"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0012.2007.00761.x"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2019.09.005"},{"key":"e_1_3_4_22_1","unstructured":"Corp. MSD. PREVYMISTM 2020. [cited 2020 February 17]. Available from: https:\/\/www.merck.com\/product\/usa\/pi_circulars\/p\/prevymis\/prevymis_pi.pdf."},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15764"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12225"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13687"},{"key":"e_1_3_4_26_1","unstructured":"Roche. Cytovene\u00ae US Prescribing Information 2018. [2019 December 11]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/209347lbl.pdf."},{"key":"e_1_3_4_27_1","unstructured":"Genentech. VALCYTE\u00ae US Prescribing Information 2018. [2019 December 11]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/021304s012 022257s007lbl.pdf."},{"key":"e_1_3_4_28_1","unstructured":"Pfizer. Foscavir\u00ae US Prescribing Information 2017. [2019 December 12]. Available from: http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=6521."},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix259"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00561-13"},{"key":"e_1_3_4_31_1","unstructured":"Takeda. Takeda\u2019s LIVTENCITY (maribavir) Approved by U.S. FDA as the First and Only Treatment for People Ages 12 and Older with Post-Transplant Cytomegalovirus (CMV) Refractory (With or Without Genotypic Resistance) to Conventional Antiviral Therapies 2021. Available from: https:\/\/www.takeda.com\/newsroom\/newsreleases\/2021\/takeda-livtencity-maribavir-approved-by-us-fda\/."},{"issue":"1","key":"e_1_3_4_32_1","first-page":"1","article-title":"Impact of cytomegalovirus complications on resource utilization and costs following hematopoietic stem cell transplant","volume":"36","author":"Schelfhout J","year":"2019","unstructured":"Schelfhout J, Bonafede M, Cappell K, et\u00a0al. Impact of cytomegalovirus complications on resource utilization and costs following hematopoietic stem cell transplant. Curr Med Res Opin. 2019;36(1):1\u20139.","journal-title":"Curr Med Res Opin"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2019.1649379"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12961"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.2001.00011.x"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwq433"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31828ee12e"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1086\/383040"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25574"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2854-2"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12732"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12877"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-06-688432"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2022.2046388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T11:26:07Z","timestamp":1729164367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2022.2046388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12,31]]}},"alternative-id":["10.1080\/13696998.2022.2046388"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2022.2046388","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,11]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-09-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-11","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}